Development of Vaccines against Visceral Leishmaniasis

Leishmaniasis is a neglected disease resulting in a global morbidity of 2,090 thousand Disability-Adjusted Life Years and a mortality rate of approximately 60,000 per year. Among the three clinical forms of leishmaniasis (cutaneous, mucosal, and visceral), visceral leishmaniasis (VL) accounts for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Krystal J., Kedzierski, Lukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170777/
https://www.ncbi.nlm.nih.gov/pubmed/21912561
http://dx.doi.org/10.1155/2012/892817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170777/
https://www.ncbi.nlm.nih.gov/pubmed/21912561
http://dx.doi.org/10.1155/2012/892817

Ejemplares similares